Where Will Viking Therapeutics Stock Be in 10 Years?
Viking Therapeutics (NASDAQ: VKTX) now ranks among the hottest biotech stocks on the market. The company's announcement in February of positive results from its phase 2 study of experimental weight loss drug VK2735 provided a huge catalyst.
The future for Viking appears to be bright. But where will this high-flying stock be in 10 years? Here are three potential scenarios.
Viking Therapeutics could be worth much more than its current market cap in 2034. It's not hard to envision a scenario where the company and its stock are thriving.
Source Fool.com
Viking Therapeutics Inc Aktie
56,72 €
2,68 %
Viking Therapeutics Inc erfreut sich mäßiger Beliebtheit, mit mehr Buy- als Sell-Einschätzungen.
Für Viking Therapeutics Inc ergibt sich mit einem Kursziel von 110 € eine mögliche Steigerung von über 50% gegenüber 56.72 €.
